Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TNF and IL23 Blocking Agents Gene Expression Ratios in the Psoriatic Arthritis Synovium

NCT04261010 is registered in ClinicalTrials.gov with Cliniques universitaires Saint-Luc- Université Catholique de Louvain as lead sponsor.

NCT NCT04261010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04261010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TNF and IL23 Blocking Agents Gene Expression Ratios in the Psoriatic Arthritis Synovium
Lead sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase
Not applicable
Overall status
Completed
Start date
January 14, 2020
Completion date
September 12, 2023
Enrollment
36 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic arthritis